Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Josefine Schulz, Franziska Kluwe, Gerd Mikus, Robin Michelet & Charlotte Kloft. (2019) Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism. Drug Metabolism Reviews 51:3, pages 247-265.
Read now
Read now
Lisa A. Tell, Karl V. Clemons, Yvonne Kline, Leslie Woods, Philip H. Kass, Marife Martinez & David A. Stevens. (2010) Efficacy of voriconazole in Japanese quail (Coturnix japonica) experimentally infected with Aspergillus fumigatus. Medical Mycology 48:2, pages 234-244.
Read now
Read now
Lyn Thomas, Lonneke Baggen, Julia Chisholm & Mike Sharland. (2009) Diagnosis and treatment of aspergillosis in children. Expert Review of Anti-infective Therapy 7:4, pages 461-472.
Read now
Read now
Articles from other publishers (23)
Hansraj Choudhary, Shreya Singh, Rachna Singh, Ritesh Agarwal, Harsimran Kaur, Anup Ghosh, Arunaloke Chakrabarti & Shivaprakash M. Rudramurthy. (2021) Rapid and Simple Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) Method for Simultaneous Quantifications of Triazole Antifungals in Human Serum. Mycopathologia 186:1, pages 27-39.
Crossref
Crossref
Camille Bouchand, David Nguyen, Philippe-Henri Secretan, Fabrice Vidal, Romain Guery, Sylvain Auvity, Jeremie F. Cohen, Fanny Lanternier, Olivier Lortholary, Salvatore Cisternino & Joël Schlatter. (2020) Voriconazole topical cream formulation: evidence for stability and antifungal activity. International Journal of Antimicrobial Agents 56:3, pages 106083.
Crossref
Crossref
Andreas H. Groll & Silke Gastine. 2020. Methods of Therapeutic Drug Monitoring Including Pharmacogenetics. Methods of Therapeutic Drug Monitoring Including Pharmacogenetics
185
224
.
Vatsal M. Patel, Navin B. Patel, Manuel J. Chan-Bacab & Gildardo Rivera. (2018) Synthesis, biological evaluation and molecular dynamics studies of 1,2,4-triazole clubbed Mannich bases. Computational Biology and Chemistry 76, pages 264-274.
Crossref
Crossref
Anshu Sharma, Sarita Aggarwal, Richa Ahluwalia, Rahul Sahay & Rimsha Rimsha. (2017) CLINICAL STUDY OF VORICONAZOLE VS. NATAMYCIN IN TREATMENT OF MYCOTIC CORNEAL ULCERS. Journal of Evidence Based Medicine and Healthcare 4:92, pages 5581-5585.
Crossref
Crossref
Takenori Niioka, Naohito Fujishima, Maiko Abumiya, Takaya Yamashita, Kumi Ubukawa, Miho Nara, Masumi Fujishima, Naoto Takahashi & Masatomo Miura. (2017) Relationship Between the CYP2C19 Phenotype Using the Voriconazole-to-Voriconazole N-Oxide Plasma Concentration Ratio and Demographic and Clinical Characteristics of Japanese Patients With Different CYP2C19 Genotypes. Therapeutic Drug Monitoring 39:5, pages 514-521.
Crossref
Crossref
S.T. Heo, S.L. Aitken, F.P. Tverdek & D.P. Kontoyiannis. (2017) How common is subsequent central nervous system toxicity in asymptomatic patients with haematologic malignancy and supratherapeutic voriconazole serum levels?. Clinical Microbiology and Infection 23:6, pages 387-390.
Crossref
Crossref
Hazem Elewa, Eman El-Mekaty, Ahmed El-Bardissy, Mary H. H. Ensom & Kyle John Wilby. (2015) Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review. Clinical Pharmacokinetics 54:12, pages 1223-1235.
Crossref
Crossref
J. D. Lemetayer, P. M. Dowling, S. M. Taylor & M. G. Papich. (2015) Pharmacokinetics and distribution of voriconazole in body fluids of dogs after repeated oral dosing. Journal of Veterinary Pharmacology and Therapeutics 38:5, pages 451-456.
Crossref
Crossref
Paul M. ManinoFabiano OliveiraMartin FickenAmy SwinfordDerek Burney. (2014) Disseminated Protothecosis Associated With Diskospondylitis in a Dog. Journal of the American Animal Hospital Association 50:6, pages 429-435.
Crossref
Crossref
Yu Liu, Xu-Feng Cao, Xin Liu, Yong-Bing Cao, Wen-Jing Chu & Yu-She Yang. (2013) Synthesis, pharmacokinetics and in vivo antifungal activity of the novel water-soluble prodrugs of itraconazole analogue YL-24. Chinese Chemical Letters 24:4, pages 321-324.
Crossref
Crossref
Xu-Feng Cao, Wen-Jing Chu, Yong-Bing Cao & Yu-She Yang. (2013) Design and synthesis of novel antifungal triazole derivatives with good activity and water solubility. Chinese Chemical Letters 24:4, pages 303-306.
Crossref
Crossref
Xin Xiong, Suodi Zhai & Jingli Duan. (2013) Validation of a fast and reliable liquid chromatography-tandem mass spectrometry (LC-MS/MS) with atmospheric pressure chemical ionization method for simultaneous quantitation of voriconazole, itraconazole and its active metabolite hydroxyitraconazole in human plasma. Clinical Chemistry and Laboratory Medicine (CCLM) 51:2, pages 339-346.
Crossref
Crossref
Markus Ruhnke, Peter Kujath & Dirk Vogelaers. (2012) Aspergillus in the Intensive Care Unit. Current Fungal Infection Reports 6:1, pages 63-73.
Crossref
Crossref
David H. Dockrell, Simon Edwards, Martin Fisher, Ian Williams & Mark Nelson. (2011) Evolving controversies and challenges in the management of opportunistic infections in HIV-seropositive individuals. Journal of Infection 63:3, pages 177-186.
Crossref
Crossref
Markus Ruhnke, Volker Rickerts, Oliver A. Cornely, Dieter Buchheidt, Andreas Glöckner, Werner Heinz, Rainer Höhl, Regine Horré, Meinolf Karthaus, Peter Kujath, Birgit Willinger, Elisabeth Presterl, Peter Rath, Jörg Ritter, Axel Glasmacher, Cornelia Lass-Flörl & Andreas H. Groll. (2011) Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. Mycoses 54:4, pages 279-310.
Crossref
Crossref
Andreas H. Groll & Thomas J. Walsh. 2009. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Feigin and Cherry's Textbook of Pediatric Infectious Diseases
3271
3308
.
Javier Pemán & Benito Almirante. (2008) Avances en el diagnóstico y tratamiento de las infecciones por levaduras: papel de los nuevos antifúngicos. Enfermedades Infecciosas y Microbiología Clínica 26, pages 38-46.
Crossref
Crossref
Carole A. SableKim M. Strohmaier & Jeffrey A. Chodakewitz. (2008) Advances in Antifungal Therapy. Annual Review of Medicine 59:1, pages 361-379.
Crossref
Crossref
A.D.M. Curtis & N. Jennings. 2008. Comprehensive Heterocyclic Chemistry III. Comprehensive Heterocyclic Chemistry III
159
209
.
Markus Ruhnke, Grzegorz Kofla, Kirsten Otto & Stefan Schwartz. (2007) CNS Aspergillosis. CNS Drugs 21:8, pages 659-676.
Crossref
Crossref
. (2006) Echinocandins for Candidemia. New England Journal of Medicine 355:26, pages 2791-2792.
Crossref
Crossref
Georg MaschmeyerAntje Haas. (2006) Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections. Future Microbiology 1:4, pages 365-385.
Crossref
Crossref